Leukemia Diagnostic
Personalized Assay Guided Cancer Therapy
for leukemia, lymphoma and advanced cancer patients with body cavity fluids
Cancer is a difficult disease to treat, with many faces and constant challenges. This is the disorder that changes over time even within the same patient. Modern science revealed why cancer can evolve and can escape even with the most promising therapies. The reason lies in the very large number of genetic errors accumulating in every cancer cell. Today we know that thousands of mutations make every cancer unique. Unique cancer requires individualized treatment.
iVV assay™ is a routine diagnostic assay informing the clinician which drug should be used.
It measures directly which medicine is the best to kill the living cancer cells that are isolated from the patient’s blood or body cavity fluids.
All available medicines can be tested. Qantascope is introducing a brand new and patented technology to assist personalized cancer therapy. HexascopeHaema™ [1] is an automated solution to perform the iVV assay™ [2].
Assay guided therapy gives a chance even for advanced cancer patients who already exhausted the standard treatment options. It may protect from the adverse effects of unjustified chemotherapy agents and prolong life by finding the few remaining effective drugs. iVV assay™ is the only dedicated solution to target tumors and prolong life.